Vancomycin is the antibiotic doctors reach for when almost nothing else will work. It's used in hospitals for serious ...
Difficult year for Biotechnology so far, down -17% YTD. Fundamentally the sector is gaining strength. Meaningful policy clarity to be achieved in 6-weeks based on election outcome. Biotechnology is ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results